Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,271 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Acute myeloid leukemia with a cryptic NUP98/PRRX2 rearrangement developing after low-dose methotrexate therapy for rheumatoid arthritis.
Chonabayashi K, Yoshida Y, Kitawaki T, Nannya Y, Nakamura M, Oshima S, Hishizawa M, Yamashita K, Ogawa S, Takaori-Kondo A. Chonabayashi K, et al. Among authors: nakamura m. Ann Hematol. 2019 Dec;98(12):2841-2843. doi: 10.1007/s00277-019-03838-0. Epub 2019 Nov 14. Ann Hematol. 2019. PMID: 31728617 No abstract available.
Successful treatment of Hodgkin lymphoma-like EBV-associated post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation with nivolumab.
Wada F, Kondo T, Nakamura M, Chonabayashi K, Nishikori M, Hishizawa M, Yamashita K, Takaori-Kondo A. Wada F, et al. Among authors: nakamura m. Ann Hematol. 2020 Apr;99(4):887-889. doi: 10.1007/s00277-020-03960-4. Epub 2020 Feb 12. Ann Hematol. 2020. PMID: 32052134 Free article. No abstract available.
EBV-associated lymphoproliferative disorder in a patient with X-linked severe combined immunodeficiency with multiple reversions of an IL2RG mutation in T cells.
Wada F, Kondo T, Nakamura M, Uno S, Fujimoto M, Miyamoto T, Honda Y, Shibata H, Izawa K, Yasumi T, Nishikori M, Takaori-Kondo A. Wada F, et al. Among authors: nakamura m. EJHaem. 2020 Oct 30;1(2):581-584. doi: 10.1002/jha2.119. eCollection 2020 Nov. EJHaem. 2020. PMID: 35845012 Free PMC article. No abstract available.
Residual disease is a strong prognostic marker in patients with acute lymphoblastic leukaemia with chemotherapy-refractory or relapsed disease prior to allogeneic stem cell transplantation.
Nakamura M, Arai Y, Hirabayashi S, Kondo T, Doki N, Uchida N, Fukuda T, Ozawa Y, Tanaka M, Sawa M, Katayama Y, Kanda Y, Shiratori S, Nakamae H, Yoshioka S, Onizuka M, Ichinohe T, Atsuta Y, Kako S. Nakamura M, et al. Br J Haematol. 2021 Jul;194(2):403-413. doi: 10.1111/bjh.17646. Epub 2021 Jun 22. Br J Haematol. 2021. PMID: 34159580 Free article.
CMV reactivation after allogeneic HCT is associated with a reduced risk of relapse in acute lymphoblastic leukemia.
Akahoshi Y, Nakasone H, Takenaka K, Yamasaki S, Nakamura M, Doki N, Tanaka M, Ozawa Y, Uchida N, Ara T, Nakamae H, Ota S, Onizuka M, Yano S, Tanaka J, Fukuda T, Kanda Y, Atsuta Y, Kako S, Yanada M, Arai Y. Akahoshi Y, et al. Among authors: nakamura m. Blood Adv. 2023 Jun 27;7(12):2699-2708. doi: 10.1182/bloodadvances.2022009376. Blood Adv. 2023. PMID: 36661335 Free PMC article.
15,271 results
You have reached the last available page of results. Please see the User Guide for more information.